Latest filing published 02 Jul 2015 for Nexvet Biopharma plc, €238.
Insider track record
No signal scores available.
Colin Giles: trading record in brief
Colin Giles is a declared insider of Nexvet Biopharma plc, with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 10 February 2015 and the latest from 1 July 2015.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 2 July 2015, the filings show an option exercise worth €238 in Nexvet Biopharma plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Colin Giles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,098 shares@ US$0.125Ordinary SharesSEC:0001171000-15-000043:0
- 3,147 shares@ US$0.125Ordinary SharesSEC:0001171000-15-000013:0
- 6,352 sharesOrdinary SharesSEC:0001632388-15-000003:0
3 of 3 declarations